Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

precision medicine

Alzheimer’s as a spectrum disorder: The promise of precision medicine

Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.

PET imaging of neurodegenerative diseases

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
Alzheimer's disease

Alzheimer’s disease: Treatment failures and future directions

A paradigm shift is needed if researchers are to find a successful for treatment for Alzheimer’s disease, argues Ai-Ling Lin of the Lin Brain Lab.
progressive condition

Dementia as a progressive condition

The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms

Can a new light-based therapy help with Alzheimer’s disease?

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Finding effective treatments for vascular dementia

Dr Doug Brown, Director of Research, Alzheimer’s Society provides details on the research into vascular dementia and explains why more work is needed Vascular dementia is the second most common type of dementia, accounting for almost one fifth of all cases. By 2025, it is estimated there will be 250,000...

Tackling cognitive decline in Alzheimer’s disease

Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease (AD) represents the most common cause of dementia, accounting for 60% to 80% of all dementia cases. There are currently only a few interventions that...

Pharmacogenomics of polypharmacy in Alzheimer’s disease

Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial
Dementia research: Translating knowledge into new treatments

Dementia research: Translating knowledge into new treatments

Chief Executive Hilary Evans highlights how Alzheimer’s Research UK is helping advance dementia research, but warns there is still more to be done
Italy's ageing population ladies walking Florence

Italy’s ageing population and the healthcare challenge

Open Access Government examines some of the statistics around Italy's ageing population, related health challenges, and policy action to address the issue Italy is currently the country with the second-highest number of older people – behind Germany. In 2013, it was estimated that more than 12 million elderly people were...
Old and young woman make personal budgets dementia friendly

Making personal budgets dementia friendly

A sea change is needed among local authorities to make personal budgets dementia friendly, argues George McNamara of the Alzheimer’s Society People with dementia and their families tell us of the very real impact personal budgets have had on their lives – from the 85-year-old woman who returned home after...
heat shock proteins mri neurodegenerative disease

The role of small heat shock proteins in human diseases

Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases Cells are frequently exposed to stress conditions that can damage their proteome, with consequences for their viability. To maintain a healthy proteome and preserve cell function, cells evolved a protein...
drug development for neurodegenerative diseases concept

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...
Alzheimer’s

Nanoimaging to cure Alzheimer’s disease

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the fifth leading cause of death for those aged 65 years and above. The disease typically starts with a difficulty to remember new information and as...

Follow Open Access Government